| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Land | 146,469 | 146,469 | ||
| Buildings and improvements | 2,252,137 | 2,249,408 | ||
| Construction in progress | 57,713 | 57,487 | ||
| Total real estate, at cost | 2,456,319 | 2,453,364 | ||
| Less accumulated depreciation | 324,855 | 306,594 | ||
| Net real estate held for investment | 2,131,464 | 2,146,770 | ||
| Life science investments | 105,240 | - | ||
| Construction loan receivable | 22,800 | 22,800 | ||
| Cash and cash equivalents | 36,671 | 99,666 | ||
| Investments | 5,258 | 5,258 | ||
| Right of use office lease asset | 621 | 731 | ||
| In-place lease intangible assets, net | 6,577 | 6,955 | ||
| Other assets, net | 29,283 | 22,875 | ||
| Total assets | 2,337,914 | 2,305,055 | ||
| Notes due 2026, net | 290,229 | 289,861 | ||
| Revolving credit facility | 50,000 | - | ||
| Building improvements and construction funding payable | 4,298 | 5,647 | ||
| Accounts payable and accrued expenses | 15,244 | 10,183 | ||
| Dividends payable | 54,793 | 54,661 | ||
| Rent received in advance and tenant security deposits | 51,196 | 51,647 | ||
| Other liabilities | 8,813 | 12,650 | ||
| Total liabilities | 474,573 | 424,649 | ||
| Preferred stock, par value 0.001 per share, 50,000,000 shares authorized 9.00 series a cumulative redeemable preferred stock, liquidation preference of 25.00 per share, 1,807,682 and 1,002,673 shares issued and outstanding at september30, 2025 and december31, 2024, respectively | 42,743 | 36,843 | ||
| Common stock, par value 0.001 per share, 50,000,000 shares authorized 28,022,975 and 28,331,833 shares issued and outstanding at september30, 2025 and december31, 2024, respectively | 28 | 28 | ||
| Additional paid-in capital | 2,110,486 | 2,107,963 | ||
| Dividends in excess of earnings | 289,916 | 264,428 | ||
| Total stockholders equity | 1,863,341 | 1,880,406 | ||
| Total liabilities and stockholders equity | 2,337,914 | 2,305,055 | ||
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)